Advertisement
U.S. markets closed

Actinium Pharmaceuticals, Inc. (ATNM)

NYSE American - NYSE American Delayed Price. Currency in USD
7.83-0.11 (-1.39%)
At close: 04:00PM EDT
7.99 +0.16 (+2.04%)
After hours: 07:56PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts5256
Avg. Estimate-0.54-0.61-2.05-1.86
Low Estimate-0.61-0.65-2.11-2.66
High Estimate-0.48-0.57-1.97-1.44
Year Ago EPS-0.43-0.43-1.37-2.05
Revenue EstimateCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts5266
Avg. EstimateN/AN/A180k3.87M
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/A1.08M22.1M
Year Ago SalesN/AN/A1.03M180k
Sales Growth (year/est)N/AN/A-82.50%2,050.00%
Earnings History12/30/20223/30/20236/29/20239/29/2023
EPS Est.-0.35-0.42-0.48-0.53
EPS Actual-0.43-0.43-0.58-0.49
Difference-0.08-0.01-0.10.04
Surprise %-22.90%-2.40%-20.80%7.50%
EPS TrendCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Current Estimate-0.54-0.61-2.05-1.86
7 Days Ago-0.54-0.61-2.05-1.86
30 Days Ago-0.54-0.61-2.05-1.86
60 Days Ago-0.54-0.61-2.05-1.9
90 Days Ago-0.54-0.61-2.05-1.9
EPS RevisionsCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesATNMIndustrySector(s)S&P 500
Current Qtr.-25.60%N/AN/AN/A
Next Qtr.-41.90%N/AN/AN/A
Current Year-49.60%N/AN/AN/A
Next Year9.30%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A